Pharma Foods International (2929) · RiskMitigated
Insufficient R&D Personnel
First written in FY2019. 1 of 2 entries say "Mitigated", first in FY2024. Latest entry: FY2024.
2entries
6years
0from disclosures
How it moved
Same theme, other companies
Acquiring and Retaining R&D Talent and the Risk of Difficulty in Finding ReplacementsA theme 21 companies write about · 21 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2024: 1 of 6 companies on the "Worse" side.
0 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 21 companies compared. The sentences above are computed from all 21.Full recordFilings, disclosures and news, newest first
- FY2024MitigatedAnnual report
「To expand its business, the Group will continue to make active efforts to secure highly capable personnel by collaborating on personnel exchanges with universities conducting joint research, participating in recruitment forums and similar events, enhancing internal training, and establishing various incentive plans. However, its staffing plans may not proceed as scheduled.」
While continuing to disclose the risk of failing to secure research personnel, the Group has specified measures including personnel exchanges with universities, recruitment, internal training, and incentives. - FY2019First statedAnnual report
「If recruitment does not proceed smoothly, the Group’s business development may be affected, including by delays in research and development.」
Delays in research and development resulting from the failure to recruit researchers with the required expertise and skills as planned are identified as a risk.